Aminopyridine derivatives as S1P1 / EDG1 receptor agonists

Details for Australian Patent Application No. 2008227979 (hide)

International Classifications

Event Publications

12 November 2009 PCT application entered the National Phase

PCT publication WO2008/114157 Priority application(s): WO2008/114157

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

9 August 2012 Section 223 Application Received

ACTELION PHARMACEUTICALS LTD An application to extend the time from 28 Oct 2011 to 28 Jul 2012 in which to request Examination has been filed . Address for service in Australia - A J PARK Level 11 60 Marcus Clarke Street Canberra ACT 2601 2012

27 September 2012 Section 223 Application Allowed

ACTELION PHARMACEUTICALS LTD The time in which to request Examination has been extended to 28 Jul 2012 . Address for service in Australia - A J PARK Level 11 60 Marcus Clarke Street Canberra ACT 2601 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.